This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Ocugen Inc. (OCGN) shed 4.48% to $6.82 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.16% to 4,359.46 and the Dow Jones Industrial Average rising 0.26% to 34,390.72. This was the stock's second consecutive day of losses. Ocugen Inc. closed $11.95 short of its 52-week high ($18.77), which the company achieved on February 8th.
The stock underperformed when compared to some of its competitors Wednesday, as Adverum Biotechnologies Inc. (ADVM) fell 3.51% to $2.20, Ocular Therapeutix Inc. (OCUL) fell 3.34% to $10.14, and Kodiak Sciences Inc. (KOD) fell 2.96% to $97.52. Trading volume (11.4 M) remained 853,188 below its 50-day average volume of 12.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 29, 2021.
(END) Dow Jones Newswires
September 29, 2021 17:13 ET (21:13 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.